Novavax (NASDAQ: NVAX) submitted an application to the FDA, seeking to amend its Emergency Use Authorization (EUA) and update its protein-based COVID-19 vaccine for the upcoming fall season.
Gaithersburg’s Novavax says it will have an updated Covid-19 vaccine ready after an FDA committee voted unanimously on the ...
Novavax (NASDAQ: NVAX) stock price has gone parabolic this year, making it one of the best-performing companies in New York.
Novavax stock zipped to a nearly two-year high Thursday after the FDA set a potential approval date for its Covid vaccine in ...
Shares of Novavax climbed Thursday after the company said it would be able to deliver a regulator-recommended vaccine against a strain of Covid-19 by September. About Dow Jones Newswires Dow Jones ...
Novavax stock hit a new 52-week high of $23.86 last week, and while it has come down from there in recent days, the stock's price remains at levels it hasn't seen since late 2022. It's not just ...
With the ongoing GameStop saga reigniting interest in meme stocks, investors, or more likely traders and speculators, are ...
Shares of vaccine stocks Moderna(NASDAQ: MRNA), Novavax(NASDAQ: NVAX), and BioNTech SE(NASDAQ: BNTX) rallied this week, ...
Anjalee Khemlani is an award-winning healthcare and business reporter at Yahoo Finance covering the entire healthcare sector, including pharma, health tech, providers, insurers, PBMs and health equity ...
Novavax NVAX submitted an application to the FDA, seeking to amend its Emergency Use Authorization (EUA) and update its ...
Novavax's stock is highly volatile due to the company's instability and inconsistent financial results. Sanofi has partnered with the company, and that has sparked a wave of excitement in Novavax ...
Novavax (NASDAQ: NVAX) stock is suddenly a buy again this year, with its stock price more than tripling since the start of 2024. Some positive developments in recent months, including a deal with ...